Guardant Health gets FDA approval for breast cancer diagnostic test

May 4, 2026 8:05 AM

Guardant Health Inc. (NASDAQ: GH) received U.S. Food and Drug Administration approval for its Guardant360 CDx liquid biopsy test as ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found